Entering text into the input field will update the search result below

ANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q4 2020 Results - Earnings Call Transcript

Mar. 09, 2021 3:06 PM ETANI Pharmaceuticals, Inc. (ANIP)
SA Transcripts profile picture
SA Transcripts

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q4 2020 Earnings Conference Call March 9, 2021 8:30 AM ET

Company Participants

Lisa Wilson - In-Site Communications, Investor Relations

Nikhil Lalwani - President & Chief Executive Officer

Stephen Carey - Chief Financial Officer

Conference Call Participants

Brandon Folkes - Cantor Fitzgerald

Elliot Wilbur - Raymond James

Dana Flanders - Guggenheim


Good morning, and welcome to today's program. My name is Maria, and I'll be your conference operator. At this time, I'd like to welcome everyone to ANI Pharmaceuticals Fourth Quarter and Year End 2020 Earnings Results and Business Update Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer period. [Operator Instructions] As a reminder, this conference call is being recorded today, March 9, 2021.

It's now my pleasure to turn the floor over to Ms. Lisa Wilson, Investor Relations for ANI Pharmaceuticals. Please go ahead.

Lisa Wilson

Thank you, Maria. Welcome to ANI Pharmaceuticals Q4 2020 Earnings Results Call. This is Lisa Wilson of In-Site Communications, Investor Relations for ANI. With me on today's call are Nikhil Lalwani, President and Chief Executive Officer and Steve Carey, Chief Financial Officer of ANI. You can also access the webcast of this call through the Investors section of the ANI website at anipharmaceuticals.com.

Before we get started, I would like to remind everyone that any statements made on today's conference call that express a belief, expectation, projection, forecast, anticipation or intent regarding future events and the Company's future performance may be considered forward-looking statements as defined by the Private Securities Litigation Reform Act. These forward-looking statements are based on information available to ANI Pharmaceuticals' management as of today and involve risks and uncertainties, including those noted in our press release issued this morning and our filings with the SEC. Such forward-looking statements are

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!

About ANIP

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on ANIP

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.